11th Annual Focus on Pharmacology Conference

D6648

The purpose of this conference is to provide pharmacology information in multiple areas, and to promote clinical excellence through improving the quality of care to patients.

The primary audience is nurse practitioners, physician assistants and advanced practice clinicians; however, the program content is relevant to the broader health care community.

Abstracts are being accepted for this event.

This activity is designed to provide information on a variety of pharmacological topics. The customized learning will occur through choices in Primary Care, Pediatric Care and Acute Care topics. Posters can be research-based or related to evidence-based practice and practice improvement. Posters must be pharmacology-related and may include decision-making regarding medication management in disease management.

Abstract deadline is Feb. 17, 2021.

Submit abstracts here

The April 16, 2021, event includes two hours of opioid continuing education.

Dr. Margaret Fitzgerald

DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP
Founder, Fitzgerald Health Education Associates, LLC
Family Nurse Practitioner, Greater Lawrence Family Health Center

April 16, 2021

• 7:45 a.m. | Opening Remarks
  Janet Shields, DNP, CRNP, PPCNP-BC
• 8 a.m. | Keynote Presenter
  Drug Update: New Products, Indications and Warnings
  Margaret Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP

  Objectives

  • Discuss the indications and mechanism of actions of new medications that have been recently approved by the FDA.
  • Identify the appropriate use of established medications that are now available generically.
  • Describe clinical situations where the aforementioned medications should be considered for use.
• 9 a.m. | What is Opioid Stewardship and How Can It Impact My Practice?
  Thomas Vissering, MBA, RPh

  Objectives

  • Describe the fundamentals of opioid stewardship.
• 10 a.m. | Break/Visit Exhibitors
• 10:30 a.m. | Keynote Presenter
  Depression and Anxiety: Latest in Treatment Recommendations
  Margaret Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP

  Objectives

  • Explain the mechanism of action of commonly prescribed psychotropic medications used in the treatment of mood disorders including depression and anxiety.
  • Describe factors influencing the choice of a psychotropic medication for the treatment of common mood disorders.
  • Identify common adverse effects and therapeutic advantages of the above-mentioned medications.
• 11:30 a.m. | Opioid Epidemic and the Commonwealth’s Response
  Meghna Patel, MHA

  Objectives

  • Describe the opioid epidemic in Pennsylvania.
  • Recognize the Commonwealth’s strategies to address the opioid epidemic in Pennsylvania.
  • List the various prevention and intervention resources available in Pennsylvania.
  • Discuss the new emerging threats due to drug-related overdoses in Pennsylvania.
• 12:30 p.m. | Adjournment

April 17, 2021

• 7:45 a.m. | Opening Remarks
  Janet Shields, DNP, CRNP, PPCNP-BC
• 8 a.m. | Concurrent Session 1
  

  1A – Pediatric Track

  Antibiotic Stewardship: It Takes a Village
  Susan E. Rzucidlo, MSN, CRNP

  Objectives

  • Describe the scope of antibiotic misuse and resistance and practice implications for advance practice providers.
  • Discuss components of an antibiotic stewardship program including evaluation of drug allergy and resources and education for staff and parents/caregivers.
  • Describe strategies for antibiotic stewardship and guidelines for care of common pediatric infections.

  1B – Acute Care Track

  Anti-Thrombotic Therapy and Management: When-Why-How
  Michele Haydo, PharmD, BCACP
  Kathaleen King-Dailey, DNP, CRNP, CHFN, CCRN

  Objectives

  • Recognize the type of patient that may be on or requiring anti-thrombotic therapy.
  • Differentiate the pharmacologic profiles of oral antiplatelet, oral anticoagulants and aspirin therapy.
  • Describe the indications of one therapy versus another.
  • Discuss the pre-operative management and post-operative management of anti-thrombotic therapy.

  1C – Primary Care Track

  Contraception Management
  Pamela Keller, MSN, BSN, CRNP, FNP-C

  Objectives

  • Describe how to initiate and manage available contraception options.
  • Identify the appropriate use of available contraception options for your patient population.
  • Identify the efficacy of available contraception options.
• 9 a.m. | Concurrent Session 2
  

  2A – Pediatric Track

  Pharmacology for Common Pediatric ENT Complaints
  Meghan Schmidt, MPAS, PA-C

  Objectives

  • List treatment options for otitis media and otitis externa.
  • Discuss management of acute nasal complaints.
  • Discuss management of chronic nasal complaints.

  2B – Acute Care Track

  Prescribing Antiepileptic Medications for Adults
  Kristen Fulton, MSN, AG-ACNP-BC

  Objectives

  • Differentiate common antiepileptic drug (AED) classes.
  • List indications of AEDs based on the American Academy of Neurology, American Family Physician, Brain Trauma Foundation and Neuro Critical Care Society guidelines.
  • Prescribe AEDs considering dosing, side effect profile, pharmacokinetics and monitoring needs.

  2C – Primary Care Track

  Follow the Yellow Brick Road to: Patient-Centered, Outcome-Driven Management of Patients with Type 2 Diabetes
  Elaine J. McGinty, MSN, CRNP, CDCES

  Objectives

  • Describe and utilize the ADA guidelines.
  • Compare and contrast SGLT-2 inhibitors and GLP-1 receptor agonists.
• 10 a.m. | Break/Visit Exhibitors
• 10:30 a.m. | Posters
• 11:30 a.m. | Concurrent Session 3
  

  3A – Pediatric Track

  COVID-19 Treatment: A Review of Past, Present and Future Therapies
  Patrick J. Gavigan, MD

  Objectives

  • Objectives to be determined.

  3B – Acute Care Track

  Pharmacologic Management of Delirium and Dementia
  Lynn Motz, DNP, CRNP, ACNP-BC

  Objectives

  • Differentiate delirium from dementia.
  • Examine appropriate use of pharmacological interventions in delirium.
  • Examine pharmacological treatment options in dementias.

  3C – Primary Care Track

  Polypharmacy in the Aging Population
  Daryl J. Gordon, MSN, CRNP, FNP-BC

  Objectives

  • Identify side effects and symptoms as a result of polypharmacy in the geriatric population.
  • Discuss examples of common medications that can cause side effects in the geriatric population.
  • List strategies to aid advanced practitioners in safe medication titration/changes.
• 12:30 p.m. | Adjournment

Directed and Supported by the Advanced Practice Advisory Board

Janet Shields, DNP, CRNP, PPCNP-BC
Committee Chair
Pediatric Nurse Practitioner
Penn State Children’s Hospital

Betsy Avinash, MSN, CRNP, FNP-C
Family Nurse Practitioner
Division of Urology, Department of Surgery
Penn State Health Milton S. Hershey Medical Center

Jackie Bailey, MSN, BSN, AGACNP-BC
Adult Critical Care Nurse Practitioner
Department of Neurosurgery
Penn State Health Milton S. Hershey Medical Center

David Brinton, MSN, CRNP, FNP-BC, AGACNP-BC
Manager, Advanced Practice Providers
Department of Surgery
Penn State Health Milton S. Hershey Medical Center

Carol Forsyth, MSN, CRNP, FNP-BC
Family Nurse Practitioner
Penn State Bone and Joint Institute

Suzanne Frazier, MS, CRNP, CHFN, NP-C
Heart Failure Nurse Practitioner, Heart Failure Disease Management Program
Penn State Heart and Vascular Institute

Rachel Fultz, MSPAS, PA-C
Physician Assistant
Division of Pediatric Pulmonology
Penn State Children’s Hospital

Jaime Halin, MHS, PA-C
Physician Assistant
Penn State Bone and Joint Institute

Pamela Keller, MSN, BSN, CRNP, FNP-C
Family Nurse Practitioner
Minimally Invasive Gynecologic Surgery
Education Specialist, Office of Advanced Practice
Penn State Health Milton S. Hershey Medical Center

Robin Kingston, MSN, CRNP, CPNP
Pediatric Nurse Practitioner
Penn State Children’s Hospital

Marnie O’Donnell, MS, PA-C
Physician Assistant, Children’s Heart Group
Pediatric Electrophysiology
Penn State Children’s Hospital

Bonnie Wilson, MS, CRNP, AGACNP-BC, ANP-C
Acute Care Nurse Practitioner
Penn State Health Milton S. Hershey Medical Center

Kristen Fulton, MSN, AG-ACPN-BC
Nurse Practitioner, Neuro Critical Care Unit
Penn State Health Milton S. Hershey Medical Center

Patrick J. Gavigan, MD
Assistant Professor of Pediatrics and Medicine (Infectious Diseases)
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Daryl J. Gordon, MSN, CRNP, FNP-BC
Lead Advanced Practitioner/Supervisor
St Luke’s Spine & Pain Associates
St Luke’s University Health Network

Michele Haydo, PharmD, BCACP
Clinical Pharmacy Specialist – Ambulatory Care
Department of Pharmacy
Penn State Health Milton S. Hershey Medical Center

Pamela Keller, MSN, BSN, CRNP, FNP-C
Family Nurse Practitioner
Minimally Invasive Gynecologic Surgery
Penn State Health Milton S. Hershey Medical Center

Kathaleen King-Dailey, DNP, CRNP, CHFN, CCRN
Heart Failure Nurse Practitioner
Penn State Health Heart and Vascular Institute

Elaine J. McGinty, MSN, CRNP, CDCES
Endocrinology
Penn State Health Milton S. Hershey Medical Center

Lynn Motz, DNP, CRNP, ACNP-BC
Associate Director of Advanced Practice
Trauma and Acute Care Surgery
Penn State Health Milton S. Hershey Medical Center

Meghna Patel, MHA
Deputy Secretary for Health Innovation
Pennsylvania Department of Health

Susan E. Rzucidlo, MSN, CRNP
Pediatric Nurse Practitioner
Ambulatory Pediatrics
Penn State Health Milton S. Hershey Medical Center

Meghan Schmidt, MPAS, PA-C
Department of Otolaryngology – Head and Neck Surgery
Penn State Health Milton S. Hershey Medical Center

Thomas Vissering, MBA, RPh
Opioid Stewardship Pharmacist
Department of Pharmacy
Penn State Health Milton S. Hershey Medical Center

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• April 16, 2021 – 4 AMA PRA Category 1 Credit(s)
• April 17, 2021 – 4 AMA PRA Category 1 Credit(s)

Nurse practitioners please note:

This program includes a maximum of 8 hours of pharmacology continuing education as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). All presentations qualify for pharmacology education.

• April 16, 2021 – 4 hours pharmacy continuing education
• April 17, 2021 – 4 hours pharmacy continuing education

This program includes a maximum of 2 hours of identification of addiction or the practices of prescribing or dispensing of opioids as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). Please see the agenda for the presentations marked with (opioid).

• April 16, 2021 – 2 hours opioid continuing education

Nurses using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing website.

These credits meet the criteria set by the ANCC, American Nurses Credentialing Center, as contact hours that are acceptable for renewal certification. Additional information is available through the American Nurses Credentialing Center.

• April 16, 2021 – 4 hours
• April 17, 2021 – 4 hours

Fees are:

• $75 for one half-day
• $150 for two half-days

To receive the following reduced nurse practitioner or physician assistant student rates, email verification of student status to ContinuingEd@pennstatehealth.psu.edu.

• $25 for one half-day
• $50 for two half-days

Fee includes cost of instruction and online handout materials.

Registrations received after April 15, 2021, will incur a $25 late fee.

Cancellations received after April 15, 2021, will be assessed a $25 processing fee.

No refunds will be made for cancellations that are received after April 12, 2021.

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact Continuing Education at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D6648